AKIN GUMP STRAUSS HAUER & FELD

Lobbying for MAYNE PHARMA (USA), INC. · Pharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $70,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to federal coverage of contraception; Issues related to prescription drug pricing and distribution platforms.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.